Jan. 8 (UPI) — The European Fee on Friday proposed to its members to buy 200 million doses of the coronavirus vaccine made by Pfizer and BioNTech with an possibility of one other 100 million extra.
The doses can be obtainable to member states within the second quarter of this yr. The European Union mentioned the transfer would enable it to purchase as much as 600 million doses complete.
“The benefit of this excellent news is: We now have already a contract — so no prolonged negotiations anymore,” European Fee President Ursula von der Leyen mentioned in an announcement. “It’s a confirmed vaccine — so the entire process of authorization is completed.
“The member states understand it — so that they know the best way to deal with it, they know the logistics behind it. And subsequently this brings certainty for the planning and it creates an extra momentum for vaccinations all through Europe and for the neighborhood,” she mentioned.
An announcement from the fee mentioned the transfer would cowl the wants of its entire EU inhabitants together with neighboring nations.
“This implies, with these two licensed vaccines, we’ve already secured an quantity of doses that we have to vaccinate 380 million Europeans,” von der Leyen mentioned. “And that is greater than 80% of the European inhabitants. And different vaccines will comply with within the coming weeks and months.”